Table 3.
Association between ABSI and cognitive impairment.
| OR (95% CI), p | |||
|---|---|---|---|
| 100ABSI | Model 1 | Model 2 | Model 3 |
| 100ABSI | 2.277 (1.993, 2.601) < 0.001 | 1.673 (1.457, 1.919) < 0.001 | 1.457 (1.261, 1.684) < 0.001 |
| 100ABSI quartile (median [range]) | |||
| Q1 (5.97 [<6.14]) | Reference | Reference | Reference |
| Q2 (6.26 [6.14–6.36]) | 1.219 (1.016, 1.464) 0.033 | 1.155 (0.960, 1.391) 0.127 | 1.131 (0.930, 1.378) 0.218 |
| Q3 (6.49 [6.37–6.63]) | 1.361 (1.137, 1.628) 0.001 | 1.162 (0.966, 1.398) 0.111 | 1.145 (0.942, 1.392) 0.175 |
| Q4 (6.86 [≥6.64]) | 2.471 (2.087, 2.926) < 0.001 | 1.706 (1.426, 2.043) < 0.001 | 1.483 (1.224, 1.796) < 0.001 |
| p for trend | <0.001 | <0.001 | <0.001 |
ABSI, a body shape index; CI, confidence interval; OR, Odds ratio.
Model 1 was unadjusted.
Model 2 was adjusted for age and sex.
Model 3 was adjusted for age, sex, residence, education, marital status, retirement, current smoking, current drinking, socializing, hypertension, diabetes, stroke, depression symptoms, SBP, DBP, FPG, TC, TG, LDL-C, HDL-C, and hsCRP.